Aureate Tradde IPO is a SME IPO of 38,98,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is . The Aureate Tradde IPO open and close dates are not available as of now. MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Manipal Health Enterprises IPO Details Details
Manipal Health Enterprises IPO is a book-built public issue aggregating to ₹9,275.22 crore. The offering comprises a fresh issue of 13.56 crore equity shares worth ₹8,000.00 crore and an offer for sale (OFS) of 2.16 crore equity shares valued at ₹1,275.22 crore. The IPO will open for subscription on July 29, 2026, and close on July 31, 2026. The basis of allotment is expected to be finalised on August 3, 2026, while the company’s shares are tentatively scheduled to list on the NSE and BSE on August 5, 2026. The price band has been fixed at ₹560–₹590 per share. Investors can apply in lots of 25 shares, requiring a minimum investment of ₹14,750 for retail applicants (calculated at the upper price band). Kotak Mahindra Capital Co. Ltd. is acting as the Book Running Lead Manager (BRLM), while KFin Technologies Ltd. has been appointed as the registrar to the issue. For complete details on the company, risk factors, financials, and the offer structure, investors should refer to the Red Herring Prospectus (RHP) of the Manipal Health Enterprises IPO.
IPO Details
| IPO Date | 29 Jul 26 |
| Listing Date | 05 Aug 26 |
| Face Value | ₹2 per share |
| Price Band | ₹560 to ₹590 |
| Lot Size | 25 |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE, BSE |
| Total Issue Size | ₹9,275 Cr |
| Fresh Issue |
₹8,000 Cr
|
| Offer for Sale | |
| Share Holding Pre Issue | 1,17,97,57,321 shares |
| Share Holding Post Issue | 1,31,53,50,541 shares |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | 1,31,53,50,541 shares |
| Retail Shares Offered | Not more than 10% of the Net Offer |
| NII Shares Offered | Not more than 15% of the Net Offer |
About Manipal Health Enterprises IPO Details.
Incorporated in 2010, Manipal Health Enterprises Limited is one of India’s leading healthcare service providers, operating an extensive network of multi-specialty hospitals, clinics, and diagnostic centres across the country. The company is a part of the renowned Manipal Group, founded by Dr. T. M. A. Pai.
Manipal Health offers a comprehensive range of healthcare services, including tertiary and quaternary care, organ transplantation, oncology, cardiology, neurology, orthopaedics, and preventive healthcare. Its hospitals are equipped with state-of-the-art medical technology and supported by highly experienced doctors, nurses, and healthcare professionals.
The company is committed to delivering high-quality, patient-centric healthcare while expanding its reach through strategic acquisitions, partnerships, continuous investment in medical infrastructure, and digital health initiatives. As of March 31, 2026, Manipal Health operated 49 hospitals with 13,037 licensed beds, along with 21 clinics across India.
As of the same date, the company employed 24,240 full-time professionals, including 11,048 nurses, 6,362 paramedics, and 6,830 administrative staff, ensuring efficient healthcare delivery and operational excellence.
Key Competitive Strengths
India’s largest multi-specialty hospital network by bed capacity, with a strong pan-India presence and market leadership across its three key regions.
The only private hospital chain in India with leadership positions in three major metropolitan cities—Bengaluru, Kolkata, and Pune— while maintaining a well-diversified presence across both metro and non-metro markets.
A trusted and widely recognised healthcare brand, preferred by patients, doctors, and healthcare professionals.
Advanced medical infrastructure and cutting-edge technology, backed by a strong focus on clinical excellence and patient outcomes.
Consistent track record of industry-leading growth, supported by robust profitability, operational efficiency, and disciplined execution.
Company Financials (Restated)
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 | |
|---|---|---|---|---|
| Assets | 24,864.50 | 14,072.08 | 10,818.83 | |
| Total Income | 10,520.52 | 8,362.79 | 6,265.17 | |
| Profit After Tax | 916.52 | 1,081.67 | 533.20 | |
| EBITDA | 2,795.94 | 2,247.07 | 1,776.60 | |
| Net Worth | 8,440.92 | 5,865.66 | 4,029.22 | |
| Amount in ₹ Crore | ||||
IPO Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited | 5,552.76 |
| 2 | Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited | 574.00 |
| 3 | General corporate purposes | 0.00 |
Key Performance Indicator (KPI)
| KPI | Mar 31, 2026 | - |
|---|---|---|
| ROE | -% | -% |
| ROCE | 21.88%% | -% |
| Debt/Equity | - | - |
| RoNW | 10.57%% | -% |
| PAT Margin | 8.87%% | -% |
| EBITDA Margin | 27.05%% | -% |
Key Performance Indicator (KPI)
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding % | 81.43% | - |
| EPS Rs | 7.77 | - |
| Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd., Kangto Investments Pte.Ltd., Imperius Healthcare Investments Pte.Ltd., Kabru Investments Pte.Ltd. | ||
IPO Registrar
- Kfin Technologies Ltd.
- 040-79615565
- manipal.ipo@kfintech.com
- Visit Website
IPO Lead Manager(s)
- Kotak Mahindra Capital Co.Ltd. .
- Axis Capital Ltd. .
- Goldman Sachs . ( India Securities Pvt.Ltd. )
- Jefferies India Pvt.Ltd. .
- JP Morgan India Pvt.Ltd. .
- UBS Securities India Pvt.Ltd. .
- DBS Bank India Ltd. .
Lead Manager Reports
Contact Details
Manipal Health Enterprises Ltd. Address
The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru, Karnataka, 560017
- 80 4936 0300
- legalcs@manipalhospitals.com
- Visit Website
IPO FAQs
-
What is the Aureate Tradde IPO?
-
How to apply in Aureate Tradde IPO through Zerodha?
Zerodha customers can apply online in Aureate Tradde IPO using UPI as a payment gateway. Zerodha customers can apply in Aureate Tradde IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aureate Tradde IPO through Zerodha
- Visit the Zerodha website and login to Console.
- Go to Portfolio and click the IPOs link.
- Go to the ' Aureate Tradde IPO ' row and click the 'Bid' button.
- Enter your UPI ID, Quantity, and Price.
- Submit IPO application form.
- Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Zerodha IPO Application Process Review for more detail.
-
When Aureate Tradde IPO will open?
The Aureate Tradde IPO dates are not announced. Please check back again after some time.
-
What is the lot size of Aureate Tradde IPO?
Aureate Tradde IPO lot size and the minimum order quantity is not available at this time. Please check again later.
-
How to apply for Aureate Tradde IPO?
You can apply in Aureate Tradde IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
-
Is online banking secure?
Repudiated and annoyances accepted the wise man therefore always holds in these matters to this principle selection he rejects pleasures to secures.
-
When is Aureate Tradde IPO allotment?
The finalization of Basis of Allotment for Aureate Tradde IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Aureate Tradde IPO allotment status.
-
When is Aureate Tradde IPO listing date ?
The Aureate Tradde IPO listing date is not yet announced. The tentative date of listing is .